gms | German Medical Science

21. Deutscher Kongress für Versorgungsforschung

Deutsches Netzwerk Versorgungsforschung e. V.

05.10. - 07.10.2022, Potsdam

The impact of COVID-19 vaccination on the social participation of immunocompromised persons – results of a multicenter observational study

Meeting Abstract

  • Gloria Heesen - Institut für Allgemeinmedizin - Universitätsmedizin Göttingen, Göttingen, Deutschland
  • Dominik Schröder - Institut für Allgemeinmedizin - Universitätsmedizin Göttingen, Göttingen, Deutschland
  • Frank Müller - Institut für Allgemeinmedizin - Universitätsmedizin Göttingen, Göttingen, Deutschland
  • Eva Hummers - Institut für Allgemeinmedizin - Universitätsmedizin Göttingen, Göttingen, Deutschland
  • Frank Klawonn - Ostfalia Hochschule für angewandte Wissenschaften, Wolfenbüttel, Deutschland
  • Marie Mikuteit - Medizinische Hochschule Hannover, Hannover, Deutschland
  • Jacqueline Niewolik - Medizinische Hochschule Hannover, Hannover, Deutschland
  • S. Steffens - Medizinische Hochschule Hannover, Hannover, Deutschland
  • Anne Cossmann - Medizinische Hochschule Hannover, Hannover, Deutschland
  • Georg Behrens - Medizinische Hochschule Hannover, Hannover, Deutschland
  • Alexandra Jablonka - Medizinische Hochschule Hannover, Hannover, Deutschland
  • Stephanie Heinemann - Institut für Allgemeinmedizin - Universitätsmedizin Göttingen, Göttingen, Deutschland

21. Deutscher Kongress für Versorgungsforschung (DKVF). Potsdam, 05.-07.10.2022. Düsseldorf: German Medical Science GMS Publishing House; 2022. Doc22dkvf250

doi: 10.3205/22dkvf250, urn:nbn:de:0183-22dkvf2501

Veröffentlicht: 30. September 2022

© 2022 Heesen et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Background and status of (inter)national research: Immunocompromised persons are at an increased risk for a severe SARS-CoV-2 infection and their safety behaviors may influence their social participation. Vaccinated persons have a lower incidence of infection and severe disease when infected compared to non-vaccinated persons. Therefore, their behavior may change and their social participation may increase after a complete vaccination.

Research question and objective: The aim of this study was to explore social participation of immunocompromised persons before and after complete COVID-19 vaccination.

Method or hypothesis: Between March and September 2021, 274 immunocompromised participants were recruited. Survey data were collected at baseline and follow-up from 194 participants including the Index for the Assessment of Health Impairments [IMET], Patient Health Questionnaire-4 [PHQ-4], subjective health status and quality of life. At baseline, participants were not yet completely vaccinated. Complete vaccination was achieved prior to the follow-up questionnaire.

Results: IMET scores decreased significantly at follow-up, indicating a higher social participation after complete vaccination. PHQ-4, subjective health status and quality of life did not differ between baseline and follow-up. There were no significant differences across sociodemographic factors. Significant PHQ-4 differences were observed regarding the population size of the participants´ home community

Discussion: Social participation of immunocompromised persons in our study increased after COVID-19 vaccination. Therefore, social participation should be explored further, especially with regards to the impact of vaccination on groups with a high health risk.

Practical implications: Immunosuppressed individuals must be adequately informed of the potentially limited protection afforded by COVID-19 vaccination.

Appeal for practice (science and/or care) in one sentence: Increased social participation was observed after COVID-19 vaccination despite uncertain vaccine protection in immunosuppressed individuals.

Funding: Sonstige Förderung; DEFEAT Corona project, funded by the European Fund for Regional Development (EFRD) (Funding No: ZW7-85152953)